metyrapone has been researched along with Hyperactivity, Motor in 1 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Excerpt | Relevance | Reference |
---|---|---|
" In the olfactory bulbectomized rat model of depression, chronic administration (14 days) of metyrapone (50 mg/kg b." | 1.30 | Metyrapone displays antidepressant-like properties in preclinical paradigms. ( Cryan, JF; Harkin, A; Healy, DG; Kelly, JP; Leonard, BE, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Healy, DG | 1 |
Harkin, A | 1 |
Cryan, JF | 1 |
Kelly, JP | 1 |
Leonard, BE | 1 |
1 other study available for metyrapone and Hyperactivity, Motor
Article | Year |
---|---|
Metyrapone displays antidepressant-like properties in preclinical paradigms.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Antidepressive Agents, Tricy | 1999 |